T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Tesla
TSLA
|
+$5.14B |
| 2 |
JPMorgan Chase
JPM
|
+$2.05B |
| 3 |
Atlassian
TEAM
|
+$2.04B |
| 4 |
NVIDIA
NVDA
|
+$1.97B |
| 5 |
Apple
AAPL
|
+$1.73B |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.32B |
| 2 |
Microsoft
MSFT
|
+$2.74B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.74B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.9B |
| 5 |
Hilton Worldwide
HLT
|
+$1.79B |
Sector Composition
| 1 | Technology | 26.88% |
| 2 | Healthcare | 17.2% |
| 3 | Consumer Discretionary | 15.14% |
| 4 | Financials | 10.69% |
| 5 | Communication Services | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Adtran
ADTN
$809M
| $935K | ﹤0.01% |
50,698
+1,043
| +2% | +$19.2K |
|
|
DM
2027
DELISTED
Desktop Metal, Inc.
DM
| $931K | ﹤0.01% |
19,633
+1,661
| +9% | +$78.8K |
|
|
EVBG
2028
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $931K | ﹤0.01% |
21,333
+3,914
| +22% | +$171K |
|
2029
CoreCivic
CXW
$2.26B
| $928K | ﹤0.01% |
83,092
-11,368
| -12% | -$127K |
|
2030
ImmunityBio
IBRX
$2.46B
| $926K | ﹤0.01% |
165,121
-26,281
| -14% | -$147K |
|
2031
OFG Bancorp
OFG
$1.95B
| $924K | ﹤0.01% |
34,675
+1,023
| +3% | +$27.3K |
|
|
VIVO
2032
DELISTED
Meridian Bioscience Inc
VIVO
| $924K | ﹤0.01% |
35,610
+2,302
| +7% | +$59.7K |
|
2033
Sally Beauty Holdings
SBH
$1.48B
| $922K | ﹤0.01% |
59,010
-327
| -0.6% | -$5.11K |
|
2034
California Resources
CRC
$4.44B
| $915K | ﹤0.01% |
20,452
+3,746
| +22% | +$168K |
|
2035
Ligand Pharmaceuticals
LGND
$3.23B
| $914K | ﹤0.01% |
13,029
+1,003
| +8% | +$70.4K |
|
2036
QCR Holdings
QCRH
$1.3B
| $908K | ﹤0.01% |
+16,045
| New | +$908K |
|
2037
ArcBest
ARCB
$1.6B
| $904K | ﹤0.01% |
11,234
+518
| +5% | +$41.7K |
|
2038
Forrester Research
FORR
$195M
| $902K | ﹤0.01% |
15,984
+241
| +2% | +$13.6K |
|
|
HEES
2039
DELISTED
H&E Equipment Services
HEES
| $902K | ﹤0.01% |
20,723
-1,362
| -6% | -$59.3K |
|
2040
Cardlytics
CDLX
$59.6M
| $901K | ﹤0.01% |
16,396
+1,092
| +7% | +$60K |
|
2041
RE/MAX Holdings
RMAX
$195M
| $899K | ﹤0.01% |
32,436
+7
| +0% | +$194 |
|
2042
The GEO Group
GEO
$3.12B
| $892K | ﹤0.01% |
134,976
+2,703
| +2% | +$17.9K |
|
2043
Domo
DOMO
$701M
| $891K | ﹤0.01% |
17,619
+2,199
| +14% | +$111K |
|
2044
Cohu
COHU
$964M
| $890K | ﹤0.01% |
30,053
+1,026
| +4% | +$30.4K |
|
2045
Astrana Health
ASTH
$1.38B
| $886K | ﹤0.01% |
18,286
+3,166
| +21% | +$153K |
|
|
VGR
2046
DELISTED
Vector Group Ltd.
VGR
| $883K | ﹤0.01% |
73,347
+2,210
| +3% | +$26.6K |
|
2047
Anywhere Real Estate
HOUS
$800M
| $882K | ﹤0.01% |
56,229
+7,214
| +15% | +$113K |
|
2048
Globalstar
GSAT
$3.79B
| $875K | ﹤0.01% |
39,694
+28,370
| +251% | +$625K |
|
|
TPIC
2049
DELISTED
TPI Composites
TPIC
| $875K | ﹤0.01% |
62,252
+3,528
| +6% | +$49.6K |
|
2050
Cracker Barrel
CBRL
$1.14B
| $873K | ﹤0.01% |
7,350
+828
| +13% | +$98.3K |
|